Study to Evaluate the Efficacy and Safety of Aripiprazole
Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
- To evaluate the efficacy of flexibly dosed aripiprazole in reducing serious behavioral
problems in Asian children and adolescents with a diagnosis of autism spectrum disorder,
as measured by change from baseline to endpoint on the irritability subscale of the
aberrant behavior checklist (ABC-I).
- To evaluate the long-term safety and tolerability of flexibly dosed aripiprazole in the
treatment of serious behavioral problems in Asian children and adolescents with a
diagnosis of autism spectrum disorder.